Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Alberta

$27,000.00

Does Amyotrophic Lateral Sclerosis begin in the brain?

FY 2025-26

Summary
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons in the brain and spinal cord. Because ALS is fatal and its prevalence is increasing, there is a need for better diagnostic biomarkers and more effective treatments. A major unresolved question is where ALS pathology begins. The “dying-forward” hypothesis suggests degeneration begins in the brain and spreads to the muscles, whereas the “dying-back” proposes the opposite direction. My MSc research will examine the temporal sequence of neurodegeneration in ALS using longitudinal biomarkers that measure anatomical changes in the brain and peripheral nerves. I will test whether degeneration in the brain precedes degeneration in the anatomically corresponding limb. A longitudinal cohort of 40 ALS participants will be assessed every four months for one year. Brain changes will be measured using cortical thickness measures from magnetic resonance imaging (MRI) in the motor cortex regions controlling the upper and lower limbs. Peripheral motor neuron loss will be assessed using motor unit number estimation (MUNE) in representative hand and leg muscles. By comparing when these changes appear over time, this study will determine whether upper motor neuron decline precedes lower motor neuron decline in the same limb regions. If the results support the dying-forward model, this would provide evidence that early diagnostic biomarkers and future therapies should focus on the motor cortex.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573154
Name
Coscarella Jaden G
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Does Amyotrophic Lateral Sclerosis begin in the brain?
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Amyotrophic Lateral Sclerosis; Electrophysiology; Magnetic Resonance Imaging; Motor Unit Number Estimation; Neurodegeneration
Abstract
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects motor neurons in the brain and spinal cord. Because ALS is fatal and its prevalence is increasing, there is a need for better diagnostic biomarkers and more effective treatments. A major unresolved question is where ALS pathology begins. The “dying-forward” hypothesis suggests degeneration begins in the brain and spreads to the muscles, whereas the “dying-back” proposes the opposite direction. My MSc research will examine the temporal sequence of neurodegeneration in ALS using longitudinal biomarkers that measure anatomical changes in the brain and peripheral nerves. I will test whether degeneration in the brain precedes degeneration in the anatomically corresponding limb. A longitudinal cohort of 40 ALS participants will be assessed every four months for one year. Brain changes will be measured using cortical thickness measures from magnetic resonance imaging (MRI) in the motor cortex regions controlling the upper and lower limbs. Peripheral motor neuron loss will be assessed using motor unit number estimation (MUNE) in representative hand and leg muscles. By comparing when these changes appear over time, this study will determine whether upper motor neuron decline precedes lower motor neuron decline in the same limb regions. If the results support the dying-forward model, this would provide evidence that early diagnostic biomarkers and future therapies should focus on the motor cortex.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Coscarella, Jaden G
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~